Contact Us
Drug Search Results
More Filters [+]

Droperidol

Alternative Names: droperidol, dehydrobenzperidol, xomolix, inapsine, innovar
Latest Update: 2024-12-10
Latest Update Note: Clinical Trial Update

Product Description

Droperidol injection is used to prevent the nausea and vomiting that may occur after surgery or diagnostic procedures. (Sourced from: https://www.mayoclinic.org/drugs-supplements/droperidol-injection-route/side-effects/drg-20063582?p=1)

Mechanisms of Action: D2 Antagonist,ADRA1A Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Intramuscular

FDA Designation: None *

Approval Status: Approved

Approved Countries: Argentina | Australia | Austria | Belgium | Brazil | Canada | Chile | China | Colombia | Croatia | Denmark | Dominican Republic | Finland | France | Germany | Greece | Hungary | Iceland | India | Ireland | Italy | Latvia | Luxembourg | Netherlands | New Zealand | Norway | Peru | Portugal | Romania | Russia | Saudi Arabia | Slovenia | South Africa | Spain | Sweden | Switzerland | Taiwan | United Kingdom | United States | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Droperidol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

08/29/2024

News Article

 Global Chlorine Market to traverse a Sluggish Progress Path at a CAGR of 4.5%, reaching USD 24.19 billion by 2034, finds the FMI Report

04/30/2024

News Article

 Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous Amisulpride as Prevention of Postoperative Nausea and Vomiting in Pediatric Patients at the Upcoming Society for Ambulatory Anesthesia (SAMBA) 2024 Annual Meeting

04/15/2024

News Article

 Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Response of Amisulpride for the Rescue Treatment of Postoperative Nausea and Vomiting (PONV) at the Upcoming ASPAN 2024 National Conference in Orlando, Florida

10/23/2023

News Article

 Eagle Pharmaceuticals Granted Unique J-Code and Pass-Through Status for BARHEMSYS® from CMS

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions